🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
40 STEMI patients who underwent primary PCI were subsequently allocated int...
Status
Completed
Location
RSUD Dr Moewardi
Start Date
2024-09-01
Trial ID
NCT06871358
Treatments Being Tested
The current available treatments for PTSD are not fully effective for cogni...
Status
Completed
Location
Ralph H. Johnson VA Medical Center, Charleston, SC
Start Date
2014-10-15
Trial ID
NCT02287038
Treatments Being Tested
This study investigates the impact of perioperative inhibition of beta-adre...
Status
Recruiting
Location
The Chaim Sheba Medical Center
Start Date
2025-03-12
Trial ID
NCT06839144
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested
SHR4640 tablets is a highly selective and potent URAT1 inhibitors,study num...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-15
Trial ID
NCT05513976
Treatments Being Tested
HIV associated neurological disorders (HAND), are a major problem even in A...
Status
Completed
Location
University of Pennsylvania School of Medicine
Start Date
2013-01
Trial ID
NCT01600170
Treatments Being Tested
This randomized, parallel cohort, two stage, double-blind, placebo-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-09-03
Trial ID
NCT01816594
Treatments Being Tested
Pulmonary Embolism (PE) is a frequent and severe disease with an annual inc...
Status
Unknown
Location
Henri Mondor Hospital
Start Date
2015-04-13
Trial ID
NCT02268903
Treatments Being Tested
The primary objective of the study is to determine whether, in patients wit...
Status
Completed
Location
Cedars-Sinai Heart Institute
Start Date
2017-03-02
Trial ID
NCT02816736
Treatments Being Tested
This is a Phase I, randomized, double-blind, placebo-controlled, first-in-h...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2022-08-26
Trial ID
NCT05391880